Franklin Resources Inc. Grows Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Franklin Resources Inc. increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 79,989 shares of the exchange traded fund’s stock after purchasing an additional 110 shares during the period. Franklin Resources Inc. owned 0.10% of SPDR S&P Biotech ETF worth $7,925,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in XBI. Bank of New York Mellon Corp increased its stake in shares of SPDR S&P Biotech ETF by 15.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,590 shares of the exchange traded fund’s stock worth $518,000 after acquiring an additional 744 shares in the last quarter. Signature Estate & Investment Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $205,000. Dearborn Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $226,000. WealthShield Partners LLC boosted its position in shares of SPDR S&P Biotech ETF by 61.6% in the 2nd quarter. WealthShield Partners LLC now owns 2,025 shares of the exchange traded fund’s stock worth $188,000 after purchasing an additional 772 shares in the last quarter. Finally, K.J. Harrison & Partners Inc grew its stake in shares of SPDR S&P Biotech ETF by 32.9% in the 2nd quarter. K.J. Harrison & Partners Inc now owns 21,000 shares of the exchange traded fund’s stock worth $1,947,000 after buying an additional 5,200 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 1.6 %

Shares of NYSEARCA:XBI opened at $91.28 on Monday. The stock has a fifty day simple moving average of $97.56 and a two-hundred day simple moving average of $97.15. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The stock has a market capitalization of $6.96 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.